BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19769063)

  • 1. [New biomarker discovered. Will the diagnosis of neuroborreliosis soon be easier (interview by Maria Weiss)?].
    Rupprecht T
    MMW Fortschr Med; 2009 Apr; 151(18):8. PubMed ID: 19769063
    [No Abstract]   [Full Text] [Related]  

  • 2. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
    Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
    Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
    Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
    J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublime diagnosis of Lyme neuroborreliosis.
    Segal BM; Logigian EL
    Neurology; 2005 Aug; 65(3):351-2. PubMed ID: 16087895
    [No Abstract]   [Full Text] [Related]  

  • 5. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis.
    Rupprecht TA; Pfister HW; Angele B; Kastenbauer S; Wilske B; Koedel U
    Neurology; 2005 Aug; 65(3):448-50. PubMed ID: 16087912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis?
    Tumani H; Cadavid D
    Neurology; 2011 Mar; 76(12):1034-5. PubMed ID: 21422454
    [No Abstract]   [Full Text] [Related]  

  • 7. Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: comparison of two ELISAs, immunoblot and CXCL13 testing.
    Wutte N; Archelos J; Crowe BA; Zenz W; Daghofer E; Fazekas F; Aberer E
    J Neurol Sci; 2014 Dec; 347(1-2):96-103. PubMed ID: 25288328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of the antibody index to diagnose lyme neuroborreliosis among seropositive patients.
    Ljøstad U; Mygland A
    Neurology; 2008 Jul; 71(2):151; author reply 151-2. PubMed ID: 18606973
    [No Abstract]   [Full Text] [Related]  

  • 9. Relevance of the antibody index to diagnose lyme neuroborreliosis among seropositive patients.
    Lanska DJ
    Neurology; 2008 Jul; 71(2):150; author reply 150-1. PubMed ID: 18606972
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple sclerosis and Lyme borreliosis.
    Schmutzhard E
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):539-43. PubMed ID: 12422598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of the antibody index to diagnose Lyme neuroborreliosis among seropositive patients.
    Blanc F; Jaulhac B; Fleury M; de Seze J; de Martino SJ; Remy V; Blaison G; Hansmann Y; Christmann D; Tranchant C
    Neurology; 2007 Sep; 69(10):953-8. PubMed ID: 17785663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved laboratory diagnostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fluid.
    Skogman BH; Croner S; Forsberg P; Ernerudh J; Lahdenne P; Sillanpää H; Seppälä I
    Pediatr Infect Dis J; 2008 Jul; 27(7):605-12. PubMed ID: 18536620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic difficulties in neuroborreliosis in children].
    Talarek E; Duszczyk E; Zarnowska H
    Przegl Epidemiol; 2007; 61(1):73-8. PubMed ID: 17702442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
    Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
    Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
    Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
    Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
    [No Abstract]   [Full Text] [Related]  

  • 16. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
    Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
    Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis.
    Rupprecht TA; Manz KM; Fingerle V; Lechner C; Klein M; Pfirrmann M; Koedel U
    Clin Microbiol Infect; 2018 Dec; 24(12):1234-1240. PubMed ID: 29674128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory diagnosis of infection caused by Borrelia burgdorferi].
    Dessau RB; Bangsborg JM; Jensen TP; Hansen K; Lebech AM; Andersen CØ
    Ugeskr Laeger; 2006 Aug; 168(34):2805-7. PubMed ID: 16942701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.
    Skogman BH; Lager M; Henningsson AJ; Tjernberg I
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid.
    Vermeersch P; Resseler S; Nackers E; Lagrou K
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):347-9. PubMed ID: 19376674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.